AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) announced today that it has licensed the US commercial rights to MuGard™, a marketed product ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE